Meridian Bioscience Sets a New Sustainability Standard in Diagnostic Assay Development with the Launch of Two New Animal-Free Immunoassay Interference Blockers

The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new immunoassay interference blockers, K-Block™, and Mouse-Free IgG.

CDC Advisory Group Under Fire for Proposed Infection Control Guidelines

Nurses, patients, and professional groups are pushing for more rigorous infection control standards from the CDC following a preview of proposed changes to its isolation

August 25, 2023

Abbott’s Jennifer Jones-McMeans on treating PAD below the knee

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Advanced peripheral artery disease (PAD) below the

May 10, 2024

LMU medical scientists discover new mechanism of alarmin release

LMU medical scientists have demonstrated that important pro-inflammatory mediators are released into the bloodstream through tiny pores in the cell membrane at a very early

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.